1 / 43

Neoplasia V Carcinogenesis

Neoplasia V Carcinogenesis. Husni Maqboul, M.D. Overview of Carcinogenic Agents. Chemical Carcinogens Physical Agents Ionizing Radiation Oncogenic Viruses. Impact of Environmental Carcinogens.

jirair
Download Presentation

Neoplasia V Carcinogenesis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Neoplasia VCarcinogenesis Husni Maqboul, M.D

  2. Overview of Carcinogenic Agents • Chemical Carcinogens • Physical Agents • Ionizing Radiation • Oncogenic Viruses

  3. Impact of Environmental Carcinogens • 80 - 90% of all cancers may be related to environmental agents including diets, lifestyles, and viruses. • Several environmental agents often act together (co-carcinogenesis).

  4. Principles of Carcinogenesis • Neoplastic transformation is a progressive process involving multiple “hits” or genetic changes. • Alterations in DNA cause changes in one or both of the following types of genes: • Proto-oncogenes • Tumor suppressor genes • Genes that regulate apoptosis

  5. Chemical Carcinogenesis ,Mechanisms • Multi-Step Process Involving: • Initiation • Promotion

  6. Initiation • Rapid ,Irreversible, and has “memory” • Results from interaction of chemical with DNA to activate a proto-oncogene or inactivate a tumor suppressor gene by formation of covalent adducts. • Chemicals that can form adducts are usually electrophiles. • Many chemical carcinogens require activation by metabolic pathways (pro-carcinogens or indirect acting carcinogens) • Initiation alone does not result in tumors. • Some initiators can subsequently act as promotors (these are “complete carcinogens”).

  7. Initiation • Some procarcinogens (e.g benzopyrene ) are activated by P-450 dependant mono-oxygenases • 10% of whites have highly inducible form of this enzyme are at higher risk to develop smoke related lung cancer • Others are detoxified by glutathione -S-transferase • 50% of whites have deleted locus, and are at higher risk to develop tobacco related lung and bladder cancer

  8. Initiation, molecular targets • Vast majority of initiating chemicals are mutagenic ( Ames Test ) • Each class of carcinogenes causes limited DNA damage • Virtually any gene can be targeted, but RAS and TP53 ( aflatoxin B1) mutations are fairly common

  9. Chemical Carcinogenesis • Polycyclic hydrocarbons (benzopyrine in cigarette smoke, smoked meet )  epoxides  covalent DNA links • Aromatic amines (β naphthylamine)  urinary bladder Ca • Nitrosamines and nitorsamides ( food amines with preservative nitrites, tobacco smoke)

  10. The Initiated Cell • Must “Survive”the insult • Must “Fix” the damage • Damaged DNA template must be replicated • Damaged DNA alone is not cancerous, so they must have other genotypic changes making them autonomous • Initiated cells are susceptible to promoters which induce proliferation, thus immortalizing the defect in a clone of proliferating neoplastic cells.

  11. Promotion • Phorbol esters, phenols,hormones, ?bile acids ,and some durgs • Promoters are usually irritants or substances that produce cell activation and proliferation . • Powerful protein kinase C activators Clonal expansion of initiated cells • Effects of promoters are reversible. • Promoters cannot induce neoplasia: i) alone, ii) if applied before initiator, iii) if applied in too small an amount for effect, or iv) if too much time elapses between applications.

  12. Radiation Oncogenesis

  13. Ultraviolet Light • Strong epidemiologic relationship to squamous cell, basal cell, and melano-carcinoma in fair skinned people. • Causes formation of pyrimidine dimers in the DNA leading to mutations. ( RAS , TP53 ) • Activation of T-suppressor cells facilitates emergence of tumor clones. • Individuals with defects in the enzymes that mediate DNA excision-repair are especially susceptible. • Xeroderma Pigmentosum • Necleotide excision repair mechanism is deficient

  14. Ionizing Radiation • Electrogagnetic: X-rays, gamma rays • Particulate : alpha, beta, positrons, protons, neutrons • Primary cosmic radiation • Bone Marrow: Acute leukemia occurs before other radiation-induced neoplasia (Seven year mean latent period in atomic bomb survivors). • Thyroid: Carcinoma occurs in 9 % of those exposed during infancy or childhood. • Lung: Increased frequency of lung cancer in miners exposed to Radon gas (an alpha particle emitter) • Skin, bone and GIT are relatively resistant

  15. Mechanisms of Radiation Carcinogenesis • Two theories: Direct interaction with the DNA or indirect damage mediated by free radicals generated from water or oxygen. • Mutation may result by either mechanism. • Mutagenicity of ionizing radiation correlates with: • Radiation quality (High linear energy transfer is most dangerous). • Dose • Dose rate • Efficiency of host DNA repair • Other host factors such as age, immune deficiency

  16. Other Radiation and Cancer • Low Level Radiation: Controversial as to whether exposure actually increases the risk of cancer. • Radon: formed from the decay of uranium-radium series of elements. In the U.S.A., 4-5% of homes have 5 times background levels of radon. This may result in 16 excess lung cancer deaths/100,000 persons. • Other: No firm data thatmicrowave radiation, electromagnetic fields, and ultrasound cause cancer.

  17. Asbestos • Asbestos fiber diameter is important • Thick fibers lodge in upper respiratory tract • Thin fibers lodge in terminal alveoli • Malignant mesothelioma of the pleural and peritoneal cavities is the characteristic tumor associated with asbestos. • Association between cancer of the lung and asbestos exposure in smokers.

  18. Foreign Body Carcinogenesis • Humans are highly resistant to foreign body carcinogenesis. • Tumors associated with parasitic infections: • Squamous carcinoma of the bladder in persons harboring Schistosoma Haematobium • Cancer of the bile ducts following infection by the liver fluke Clonorchis sinensis

  19. Viral Carcinogenesis • DNA oncogenic viruses • Transforming DNA viruses integrate into the host genome, during this process , they loose some genes essential for their complete replication. Early viral genes, however, are transcribed , and expressed in transformed cells.

  20. Viral oncogenesis, DN A viruses • Human Papillomavirus • Types 1,2,4, and 7 cause squamous papillomata and linked to SCC of the cervix, anogenital region, oral and laryngeal cancers • Types 16,18 and to a lesser extent 31,33,35 and 51 are found in 85% of invasive SCC of the cervix and its precursors • Types 6 and 11 genital warts with low malignant potential ( Episomal non integrated viral genome)

  21. Viral oncogenesis, DN A viruses • Early viral E7 • protein binds to underphosphorylated pRb, releasing E2F transcription factor • Inactivates CDK inhibitors • Activates cyclins • E6 protein • binds to and facilitates degradation of TP53 • Promotes degradation of BAX • Activates telomerase • These viral products bind with high affinity in high risk forms of HPV • Some TP53 alleles are more susceptible to degradation by E6 viral gene product ( arginine -instead of porline form ) • Co-factor role of smoking, infection etc.

  22. Viral oncogenesis, DN A viruses • Epstein-Barr Virus • Burkitt lymphoma ( African Form ) • Naso-Pharyngeal Carcinoma • Some cases of H.D • B- Cell NHL • Acts as a polyclonal B-Cell Mitogen

  23. Latent infection EBV circularizes into a nuclear “Episome” No viral replication, and no cell death ( Immortalization) Expression of viral proteins Latent Membrane Protein 1 (LMP1): Up regulation of BCL2 preventing apoptosis Activation of growth (mimicking CD40 surface signal) EBNA-2 Activates Cyclin D & src forming genes

  24. Viral oncogenesis, DNA viruses • Kaposi Sarcoma Herpesvirus ( KSHV ) • Genomic sequences found in all cases including HIV negative cases • Encodes several genes that participate in cell proliferation ( IL-6, chemokine MIP-1alpha, G protein, Cyclin D and BCL-2 ) • Encodes growth promoting factors such as IL-1, TNF-a that stimulate growth of spindle cells in autocrine and paracrine fashion • HIV infected B cells encode soluble tat ( transactivating proteins )

  25. Viral oncogenesis, DN A viruses • Hepatitis B Virus • Hepatocellular Carcinoma • Indirect, possibly multifactorial effect • Injury and regenerative hyperplasia • HBx protein : Activation of growth promoting genes , activation of RAS-MAP kinase , • Rearrangement of chromosomes • Interferes with TP53 activity • Hepatitis C virus • Liver injury and regeneration ( Fertile soil for mutations

  26. Slow transforming viruses Don’t have oncogens, replication competent Leukemia in rodents Insertional mutagenesis Acute transforming viruses All except one ( Rous Sarcom Virus ) have lost their replication genes, and placed new set ( V-oncs ) instead V-oncs ( V-SRC, V-ABL, V-MYB) integration into genome  C-oncs Viral oncogenesis, RNA viruses

  27. Viral oncogenesis, RNA viruses • Human T-Cell Leukemia Virus 1 (HTLV-1) • Associated with T-cell leukemia\lymphoma in Japan and Caribbean basin • Tropism for CD4 T-Cells • No V-oncs • Contains pX region in the genome, includes tax gene, that activates transcription of c-fos, c-sis that code for cytokine IL-2 and its receptor and GM-CSF • tax also inhibits CDK4 and TP53 normal inhibition • Demyelinating neurologic disorder (Tropical spastic paraparesis )

  28. TCLL

  29. Helicobacter pylori • Gastric carcinoma in about 3% of infected individuals after decades • Chronic gastritis  atrophy intestinal metaplasia  dysplasia  cancer • Gastric lymphoma • B-cell lymphoma • MALToma • H. pylori  reactive T-cells  polyclonal B-cell activation

More Related